Patent · US Active

Neutralizing monoclonal antibodies to IL-25 and uses thereof

US11492397B2 · kind B2 · utility

0Cited by
2References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 9, 2017
Grant dateNov 8, 2022
Priority date—
Expiry dateMay 17, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compositions and methods related to IL-25 binding molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.